Patient-reported symptoms, functioning, and quality of life (QoL) in patients treated with cemiplimab monotherapy for first-line treatment of advanced NSCLC with PD-L1 >= 50%: Results from EMPOWER-Lung 1 study.
Copy For Citation
Gumus M., Chen C., Ivanescu C., Kilickap S., Bondarenko I., Ozguroglu M., ...More
JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.15, 2021 (SCI-Expanded)
-
Publication Type:
Article / Abstract
-
Volume:
39
Issue:
15
-
Publication Date:
2021
-
Doi Number:
10.1200/jco.2021.39.15_suppl.9078
-
Journal Name:
JOURNAL OF CLINICAL ONCOLOGY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
-
Istanbul University Affiliated:
Yes